BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 2409037)

  • 1. In vitro restoration of immune responses in aging humans by isoprinosine.
    Tsang KY; Pan JF; Swanger DL; Fudenberg HH
    Int J Immunopharmacol; 1985; 7(2):199-206. PubMed ID: 2409037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An in vitro study on the effects of isoprinosine on immune responses in cancer patients.
    Tsang KY; Fudenberg HH; Pan JF; Gnagy MJ; Bristow CB
    Int J Immunopharmacol; 1983; 5(6):481-90. PubMed ID: 6198297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Restoration of immune responses of aging hamsters by treatment with isoprinosine.
    Tsang KY; Fudenberg HH; Gnagy MJ
    J Clin Invest; 1983 Jun; 71(6):1750-5. PubMed ID: 6190840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo effect of isoprinosine on interleukin-2 production, lymphocyte mitogenesis and NK activity in normal and cyclophosphamide immunosuppressed mice.
    Barasoain I; Rejas MT; Ojeda G; Portolés MP; Rojo JM
    Int J Immunopharmacol; 1986; 8(5):509-15. PubMed ID: 2428762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isoprinosine enhances PHA responses and has potential effect on natural killer cell (NK) activity of uremic patients in vitro.
    Silvennoinen-Kassinen S; Karttunen R; Tiilikainen A; Huttunen K
    Nephron; 1987; 46(3):243-6. PubMed ID: 2442634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of human T lymphocyte functions by isoprinosine.
    Rey A; Cupissol D; Thierry C; Esteve C; Serrou B
    Int J Immunopharmacol; 1983; 5(1):99-103. PubMed ID: 6188707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Partial restoration of impaired interleukin-2 production and Tac antigen (putative interleukin-2 receptor) expression in patients with acquired immune deficiency syndrome by isoprinosine treatment in vitro.
    Tsang KY; Fudenberg HH; Galbraith GM; Donnelly RP; Bishop LR; Koopmann WR
    J Clin Invest; 1985 May; 75(5):1538-44. PubMed ID: 2581997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isoprinosine restores in vitro T lymphocyte functions of cyclophosphamide immunosuppressed mice.
    Barasoain I; Rejas MT; Portoles MP; Ojeda G; Rojo JM
    Int J Immunopharmacol; 1987; 9(4):489-96. PubMed ID: 2442109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preliminary characterization in mice of the effect of isoprinosine on the immune system.
    Vecchi A; Sironi M; Spreafico F
    Cancer Treat Rep; 1978 Nov; 62(11):1975-9. PubMed ID: 83191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isoprinosine effects on interleukin-1 production in acquired immune deficiency syndrome (AIDS).
    Tsang KY; Donnelly RP; Galbraith GM; Fudenberg HH
    Int J Immunopharmacol; 1986; 8(4):437-41. PubMed ID: 2427461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacologic immunoenhancement in the elderly: in vitro effects of isoprinosine.
    Delafuente JC; Panush RS
    Clin Immunol Immunopathol; 1988 Jun; 47(3):363-7. PubMed ID: 2453315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of isoprinosine and NPT 15392 on interleukin-2 (IL-2) production.
    Wiranowska-Stewart M; Hadden JW
    Int J Immunopharmacol; 1986; 8(1):63-9. PubMed ID: 2420734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of isoprinosine on lymphocyte function in virus-infected feeder pigs.
    Flaming KP; Blecha F; Fedorka-Cray PJ; Anderson GA
    Am J Vet Res; 1989 Oct; 50(10):1653-7. PubMed ID: 2478051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isoprinosine as an immunopotentiator in an animal model of human osteosarcoma.
    Tsang KY; Fudenberg HH
    Int J Immunopharmacol; 1981; 3(4):383-9. PubMed ID: 6174468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Action of isoprinosine on the "in vitro" activation of human lymphocytes (author's transl)].
    Morin A; Griscelli C; Daguillard F
    Ann Immunol (Paris); 1979; 130C(4):541-51. PubMed ID: 91345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of isoprinosine on lymphocyte proliferation and natural killer cell activity following thermal injury.
    Singh H; Herndon DN
    Immunopharmacol Immunotoxicol; 1989; 11(4):631-44. PubMed ID: 2483407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunopharmacology of the hypoxanthine containing compounds isoprinosine and NPT 15392.
    O'Neill BB; Ginsberg T; Hadden J
    Prog Clin Biol Res; 1984; 161():525-41. PubMed ID: 6207547
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effects of inosiplex on host defense against infections (author's transl)].
    Ohnishi H; Kosuzume H; Inaba H; Shimada S; Tajima H; Suzuki Y
    Kansenshogaku Zasshi; 1981 Jul; 55(7):479-89. PubMed ID: 6173449
    [No Abstract]   [Full Text] [Related]  

  • 19. Isoprinosine potentiation of human peripheral blood mononuclear cell response to mitogens: kinetics and effect on expression of the IL-2 receptor and the activity of interleukin 2.
    Lomnitzer R
    J Clin Lab Immunol; 1988 Oct; 27(2):91-6. PubMed ID: 2469797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulatory effect of isoprinosine on lymphocyte proliferative response under immunodepressive conditions.
    Portolés A; Ojeda G; Rojo JM; Portolés MP; Barasoain I
    J Immunopharmacol; 1983; 5(3):245-56. PubMed ID: 6197489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.